Antihypertensive pharmacotherapy of patients in primary care with either a statutory or private health insurance;Antihypertensive Medikamentöse Therapie von Gesetzlich und Privat Versicherten Patienten in der Primärversorgung

Medizinische Klinik

Volumn 104, Issue 2, 2009, Pages 108-113

  Laux, Gunter ^a   Szecsenyi, Joachim ^a   Miksch, Antje ^a   Grün, Barbara ^a,b   Gutscher, Andreas ^a   Rosemann, Thomas ^c   Kühlein, Thomas ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b AQUA Institut fur Angewandte Qualitatsforderung und Forschung im Gesundheitswesen GmbH   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Angiotensin II receptor blockers; CONTENT; Hypertension; ICPC; Primary care; Private health insurance

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH PRACTITIONER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIMARY MEDICAL CARE; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; COMORBIDITY; COST-BENEFIT ANALYSIS; DIURETICS; DRUG COSTS; FEMALE; GERMANY; HUMANS; HYPERTENSION; INSURANCE, HEALTH; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PRIMARY HEALTH CARE; PRIVATE SECTOR;

EID: 61849120070     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-009-1028-4     Document Type: Article

References (29)

1. J. Chalmers 1999 WHO-ISH Hypertension Guidelines Committee. 1999 guidelines for management of hypertension J Hypertens 17 151 85
2. Arzneimittelkommisssion der Deutschen Ärzteschaft, Hrsg. Therapieempfehlungen der Arzneimittelkommission der Deutschen Ärzteschaft - Arterielle Hypertonie, 2. Aufl. Köln: Deutscher Ärzte-Verlag, 2004.
3. C. Prugger P. Heuschmann U. Keil 2006 Epidemiologie der Hypertonie in Deutschland und weltweit Herz 31 287 93
4. L.H. Lindholm B. Carlberg O. Samuelsson 2005 Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis Lancet 366 1545 53
5. D.B. Matchar D.C. [tmp] McCrory L.A. Orlando 2008 Systematic review: Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension Ann Intern Med 148 16 29
6. Blood Pressure Lowering Treatment Trialists' Collaboration. 2003 Effect of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials Lancet 362 1527 35
7. Blood Pressure Lowering Treatment Trialists' Collaboration. 2008 Effect of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials BMJ 336 1121 3
8. G. Laux T. Koerner T. Rosemann 2005 The CONTENT project: a problem-oriented, episode-based electronic patient record in primary care Inform Prim Care 13 249 55
9. G. Laux T. Rosemann T. Körner 2007 Detaillierte Erfassung von Inanspruchnahme, Morbidität, Erkrankungsverläufen und Ergebnissen durch episodenbezogene Dokumentation in der Hausarztpraxis innerhalb des Projekts CONTENT Gesundheitswesen 69 284 91
10. Lamberts H, Wood M, eds. ICPC. International Classification of Primary Care. Oxford: Oxford University Press, 1987.
11. Wissenschaftliches Institut der AOK. 2008 ATC/ DDD-Klassifikation Wissenschaftliches Institut der AOK Berlin Wissenschaftliches Institut der AOK. ATC/ DDD-Klassifikation. Berlin: Wissenschaftliches Institut der AOK, 2008 ( http://www.wido.de/arz- atcddd-klassifi.html, Zugriff am 4. 6. dy2008).
12. J. O'Halloran G.C. Miller H. Britt 2004 Defining chronic conditions for primary care with ICPC-2 Fam Pract 21 381 6
13. G. Laux T. Kühlein T. Rosemann 2008 Co- and multimorbidity patterns in primary care based on episodes of care: results from the German CONTENT project BMC Health Services Res 8 14
14. H. Mann D. Whitney 1947 On a test of whether one of two random variables is stochastically larger than the other Ann Math Stat 18 50 60
15. Fisher RA. Statistical methods for research workers. Edinburgh-London: Oliver & Boyd, 1970.
16. Bonferroni CE. Teoria statistica delle classi e calcolo delle probabilità. Pubblicazioni del R Istituto Superiore di Scienze Economiche e Commerciali di Firenze, 8. Firenze: R Istituto Superiore di Scienze Economiche e Commerciali, 1936:3-62.
17. D. Pittrow W. Kirch P. Bramlage 2004 Patterns of antihypertensive drug utilization in primary care Eur J Clin Pharmacol 60 135 42
18. B. Dahlof R.B. Devereux S.E. Kjeldsen 2002 Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 995 1003
19. P.V. Dicpinigaitis 2006 Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines Chest 129 Suppl 169 73
20. L.G. Howes D. Tran 2002 Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema? Drug Saf 25 73 6
21. G. Picksak D.O. Stichtenoth 2007 Are AT1 receptor antagonists an alternative to ACE inhibitors in angioedema? Med Monatsschr Pharm 30 415 7
22. K. Kolasinska-Malkowska K.J. Filipiak A. Gwizdala 2008 Current possibilities of ACE inhibitor and ARB combination in arterial hypertension and its complications Expert Rev Cardiovasc Ther 6 759 71
23. M.R. Weir 2007 Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Clin Ther 29 1803 24
24. C. Phillips 2007 Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials Arch Intern Med 167 1930 6
25. A. Simmenroth-Nayda E. Hummers-Pradier T. Ledig 2006 Prescription of generic drugs in general practice. Results of a survey of general practitioners Med Klin 101 705 10
26. V. Glaab M. Ihrig H. Potthast 2003 Hydrochlorothiazid-Präparate im Vergleich Pharm Ztg 148 24 7
27. A. Kaunzinger 2004 Präparate mit 20 mg Enalapril im Qualitätsvergleich Pharm Ztg 149 827 31
28. D. Krumme A. Kaunzinger J. Petri 2004 Captopril 25 mg-Tabletten im Test Pharm Ztg 149 3164 88
29. A. Roth-Isigkeit S. Harder 2005 Reporting the discharge medication in the discharge letter. An explorative survey of family doctors Med Klin 100 87 93